Breast Cancer Trial, Recruiting NCT07299812 Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07299812
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with early to mid-stage breast cancer (stage I, II, or III) and your doctor has recommended radiation therapy
  • Your breast cancer is either invasive (has grown into surrounding tissue) or is a type called DCIS (an early form found in the milk ducts)
  • Your radiation treatment is planned using one of two specific modern techniques (3D-CRT or IMRT/VMAT) (confirm with trial site)
  • You are able to hold your breath in a controlled way during treatment using a special breathing device, or you are able to receive treatment while breathing normally if the breath-hold method is not suitable for you
  • You are 18 years old or older
  • You are willing and able to sign a consent form allowing your data to be used anonymously for research

Who may not be able to join:

  • You have serious health problems or significant hearing loss
  • You have a history of severe heart or lung conditions that would make radiation therapy unsafe for you
  • You are unable or unwilling to sign a consent form for your data to be used anonymously for research
  • You have a medical reason that means radiation therapy is completely ruled out, such as being pregnant or being unable to stay in the correct position during treatment

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +39 0382503133

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Registry
ClinicalTrials.gov
Start date
23 May 2024
Est. completion
1 April 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in mean heart dose (Dmean, Gy) with ABC-assisted DIBH; Change in mean dose (Dmean, Gy) to cardiac substructures with ABC-assisted DIBH; Change in maximum dose (Dmax, Gy) to cardiac substructures with ABC-assisted DIBH

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov